Clinical analysis of pelvic lymphadenectomy in 86 patients with advanced ovarian carcinoma
- VernacularTitle:86例晚期卵巢癌盆腔淋巴结清除术的临床分析
- Author:
Ying YANG
;
Baolin DU
;
Zheng HE
- Publication Type:Journal Article
- From:Journal of Third Military Medical University
2001;23(5):586-587
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical significan ce of pelvic lymphadenectomy in advanced ovarian carcinoma. Methods A total of 86 cases of advanced ovarian cancer with surgical treatment were assigned to 3 groups according to the size of residual focus and the performanc e of pelvic lymphadenectomy. Group A consisted of 42 cases with pelvic lymphaden ectomy and the diameter of residual focus smaller than 2 cm; Group B, 26 cases, underwent pelvic lymphadenectomy but with the residual focus larger than 2 cm; Group C con sisted of 18 cases without pelvic lymphadenectomy and the diameter of residual f ocus larger than 2 cm. All patients received CAP chemotherapy for 6 to 8 course of treatment and were in similar clinical stages and pathological grading. Results The 5 year survival rate was 30.1% (13/42) in Group A, and 11.5% (3/26) in Group B with significant difference (P<0.05). Group C's 5 year survival rate was 11.1%(2/18). No significant difference was found betwee n Group B and C. Conclusion Application of pelvic lymphadenecto my on those with residual focus less than 2 cm can apparently improve the patien ts' survival rate. But when the diameter of the focus is larger than 2 cm, pelvi c lymphadenectomy is not necessary.
